Javier Fernández

Mr. Javier Fernández

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Journal of Functional Foods
Verified
Journal Article
Closed access
JFJavier Fernández
Javier Fernández
SRSaúl Redondo-Blanco
Saúl Redondo-Blanco
IGIgnacio Gutiérrez-Del-Río
Ignacio Gutiérrez-Del-Río
EMElisa M. Miguélez
Elisa M. Miguélez
CVClaudio J. Villar
Claudio J. Villar
FLFelipe Lombó
Felipe Lombó

1 September 2018 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
IGIgnacio Gutiérrez-Del-Río
Ignacio Gutiérrez-Del-Río
JFJavier Fernández
Javier Fernández
FLFelipe Lombó
Felipe Lombó

1 November 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JFJavier Fernández
Javier Fernández
BSBlanca Silván
Blanca Silván
RERodrigo Entrialgo3
Rodrigo Entrialgo3
CVClaudio J. Villar
Claudio J. Villar
Raffaele CapassoRaffaele Capasso
Raffaele Capasso
Raquel AbaloRaquel Abalo
Raquel Abalo
Flavonoids are plant bioactive compounds of great interest in nutrition and pharmacology, due to their remarkable properties as antioxidant, anti-inflammatory, antibacterial, antifungal and antitumor drugs. More than 5000 different flavonoids exist in nature, with a huge structural diversity and a plethora of interesting pharmacological properties. In this work, five flavonoids were tested for their potential use as antitumor drugs against three CRC cell lines (HCT116, HT-29 and T84). These cell lines represent three different stages of this tumor, one of which is metastatic. Xanthohumol showed the best antitumor activity on the three cancer cell lines, even better than that of the clinical drug 5-fluorouracil (5-FU), although no synergistic effect was observed in the combination therapy with this drug. On the other hand, apigenin and luteolin displayed slightly lower antitumor activities on these cancer cell lines but showed a synergistic effect in combination with 5-FU in the case of HTC116, which is of potential clinical interest. Furthermore, a literature review highlighted that these flavonoids show very interesting palliative effects on clinical symptoms such as diarrhea, mucositis, neuropathic pain and others often associated with the chemotherapy treatment of CRC. Flavonoids could provide a double effect for the combination treatment, potentiating the antitumor effect of 5-FU, and simultaneously, preventing important side effects of 5-FU chemotherapy.

14 March 2017 in Frontiers in Pharmacology
Verified
Journal Article
Open access
SRSaúl Redondo-Blanco
Saúl Redondo-Blanco
JFJavier Fernández
Javier Fernández
IGIgnacio Gutiérrez-Del-Río
Ignacio Gutiérrez-Del-Río
CVClaudio J. Villar
Claudio J. Villar
FLFelipe Lombó
Felipe Lombó
Combination therapy consists in the simultaneous administration of a conventional chemotherapy drug (or sometimes, a radiotherapy protocol) together with one or more natural bioactives (usually from plant or fungal origin) of small molecular weight. This combination of anticancer drugs may be applied to cell cultures of tumor cells, or to an animal model for a cancer type (or its xenograft), or to a clinical trial in patients. In this review, we summarize current knowledge describing diverse synergistic effects on colorectal cancer cell cultures, animal models and clinical trials of various natural bioactives (stilbenes, flavonoids, terpenes, curcumin and other structural families), which may be important with respect to diminish final doses of the chemotherapy drug, although maintaining its biological effect. This is important as these approaches may help reduce side effects in patients under conventional chemotherapy. Also, these molecules may exerts their synergistic effects via different cell cycle pathways, including different ones to those responsible of resistance phenotypes: transcription factors, membrane receptors, adhesion and structural molecules, cell cycle regulatory components and apoptosis pathways.

1 January 2020 in Journal of Food Protection
Verified
Journal Article
Closed access
SRSaúl Redondo-Blanco
Saúl Redondo-Blanco
JFJavier Fernández
Javier Fernández
SLSara López-Ibáñez
Sara López-Ibáñez
EMElisa M. Miguélez
Elisa M. Miguélez
CVClaudio J. Villar
Claudio J. Villar
FLFelipe Lombó
Felipe Lombó
Synthetic food additives generate a negative perception in consumers. This fact generates an important pressure on food manufacturers, searching for safer natural alternatives. Phytochemic... HIGHLIGHTS Phytochemicals show antifungal activity, and they act in a synergistic manner. Polyphenols are effective against important crop pathogenic fungi. Most relevant antifungal thiols are alli...

31 August 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
JFJavier Fernández
Javier Fernández
FMF. Javier Moreno
F. Javier Moreno
AOAgustín Olano
Agustín Olano
Alfonso ClementeAlfonso Clemente
Alfonso Clemente
CVClaudio J. Villar
Claudio J. Villar
FLFelipe Lombó
Felipe Lombó
Colorectal cancer (CRC) is one of the most common neoplasias worldwide, and its incidence is increasing. Consumption of prebiotics is a useful strategy in order to prevent this important disease. These nutraceutical compounds might exert protective biological functions as antitumors. In order to test the chemopreventive effect of GOS-Lu (galacto-oligosaccharides derived from lactulose) prebiotic preparation against this cancer, an animal model (Rattus norvegicus F344) was used. In this model, two doses of azoxymethane (10 mg/kg) and two treatments with dextran sodium sulfate (DSS) were administered to the animals. Animals were fed for 20 weeks, and either control drinking water or drinking water containing 10% (w/w) GOS-Lu prebiotic preparation was provided to them. Animals were sacrificed after those 20 weeks, and their digestive tract tissues were analyzed. The results revealed a statistically significant reduction in the number of colon tumors in the GOS-Lu cohort with respect to control animals. Metagenomics sequencing was used for studying colon microbiota populations, revealing significant reductions in populations of pro-inflammatory bacteria families and species, and significant increases in interesting beneficial populations, such as Bifidobacterium. Therefore, oral administration of the prebiotic GOS-Lu preparation may be an effective strategy for preventing CRC.